Illinois Sues Subsys Maker For Off-Label Promotion Of Opioid Cancer Drug

(August 26, 2016, 1:44 PM EDT) -- CHICAGO — The Illinois attorney general on Aug. 25 filed a state consumer fraud complaint asking that Insys Therapeutics Inc. be enjoined from doing business in the state for its off-label promotion of the fentanyl-based opioid Subsys (The People of the State of Illinois v. Insys Therapeutics, Inc., No. 2016-CH-11216, Ill. Cir., Cook Co.).

(Complaint available. Document #28-160901-012C.)

The complaint, filed in the Cook County Circuit Court, asks the court to find that Insys violated Section 2 of the Illinois Consumer Fraud Act (815 Illinois Compiled...
To view the full article, register now.